XTL Biopharmaceuticals Ltd.

📍 Raanana, Israel🗓 Founded 1993👥 3 employees💰 Last funded 2021
Pharmaceutical Manufacturing🌐 xtlbio.com
Website LinkedIn
XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB, TASE:XTLB.TA) is a clinical-stage biotech company focused on the development of pharmaceutical products for the treatment of autoimmune diseases including lupus. The Company’s lead drug candidate, hCDR1, is a world-class clinical asset for the treatment of systemic lupus erythematosus (SLE). Treatments currently on the market for SLE are not effective enough for most patients and some have significant side effects. Robust clinical data on hCDR1 has been produced in three clinical trials with 400 patients and over 200 preclinical studies with data published in more than 40 peer reviewed scientific journals.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1993
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in XTL Biopharmaceuticals Ltd.?
XTL Biopharmaceuticals Ltd. has 1 investors on record on gritt.io.
When did XTL Biopharmaceuticals Ltd. last raise funding?
The most recent investment in XTL Biopharmaceuticals Ltd. recorded on gritt.io was in 2021.
When was XTL Biopharmaceuticals Ltd. founded?
XTL Biopharmaceuticals Ltd. was founded in 1993.
What industry is XTL Biopharmaceuticals Ltd. in?
XTL Biopharmaceuticals Ltd. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is XTL Biopharmaceuticals Ltd. based?
XTL Biopharmaceuticals Ltd. is headquartered in Raanana, Israel.